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Growth hormone (GH) increases plasma T~ and decreases plasma T4 in i 8-day old chicken embryos, in newly hatched chicks and in adult chickens 
within 2 h after injection. The in rive increase in T~ can be linked to an increased in vitro T~ recove~ from liver homogenates incubated with T.~. 
Specific type I and type Ill deiodina~e t sts (5'D-! and 5D-III), however, show that GH has no effect at all on the amount of hepatic type I enzyme 
(catalyzing T.~ deiodination to T~) bat acutely decreases the amount of type III enzyme (catalyzing T~ deiodination). Thh suggests that the 
GH-indueed increas~ inplasma T~ is not due to an increased T.a production, but is the result of a decreased T~ breakdown. The lack era  stimulatory 
effect of GH injection in 3-day-old fed chicks might be the combined result of a low hepatic type Ill enzyme level and a low GH rew~ptor availability 
at that stage. 
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1. INTRODUCTION 
The stimulatory effect of growth hormone (GH) ad- 
ministration on circulating 3,Y,5-triiodothyronine (T3) 
levels has been demonstrated in a variety of vertebrates. 
In fish, it was shown in eels [1] and in rainbow trout [2]. 
In birds, T3 rises were found in chickens [3,4] and quail 
(Kahn et al., unpublished results) and for mammals a
stimulation was reported in man [5-8], in newborn 
lambs [9], in cattle [10] and in dwarf goats [11]. In most 
of these studies the in vivo effect of GH could be linked 
to an increased in vitro T~ recovery from liver homoge- 
hates or microsomal fractions incubated with 3,3'..5,5'- 
tetraiodothyronine (T4), and it was concluded that GH 
stimulates the 5"-monodeiodination (5'D) ofT4 to T~. In 
the rainbow trout and the eel, this indeed seems the 
most probable xplanation, since under normal condi- 
tions only 5'D activity is found and T3 itself is not a 
substrate for further deiodination [1,12]. In birds and 
mammals, however, both 5'D and 5-monodeiodination 
(SD) activity are present. This results in a far more 
complex degradation pattern. T4 can be converted by' 
5'D to T3 and by 5D to 3,3',5'-triiodothyronine (rT~), 
while T3 can be further deiodinated by 5D to 3,Y-diio- 
dothyronine (T~), and these processes all influence the 
final T3 concentration measured in the in vitro test. 
In mammals, different types of iodothyronine d iodi- 
hating enzymes (type I, II and III) have been character- 
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ized (review [13]), and related en~mes eem to be pres- 
ent in other vertebrates. It has been shown that in 
chicken liver both type I and type Ill activity are present 
and that the relative importance of both types of en- 
zymes changes during late embryonic and early post- 
hatch life [14-16]. During this same period, considera- 
ble changes have been found in the circulating GH lev- 
els and the total amount of hepatic GH receptors 
[15,17]. In view of the changing effects of a chicken GH 
(cGH) injection on peripheral monodeiodination activ- 
ity during embryonic, early posthatch and adult life 
[18,19], it seemed interesting to investigate the acute 
effect of GH on the amount of type I and type III 
enzyme separately. 
In the present study, hepatic type I (5'D-I) and type 
III (5D-III) activity have been measured following a 
single cGH injection in 18-day-old embryos (El8), 
newly hatched chicks (CO), chicks of 3 days old (C3) and 
adult chickens. In addition, plasma GH levels and he- 
patic GH receptor numbers have been measured to look 
for possible interactions with the changing effectiveness 
of the injected GH to increase plasma T~. 
2. MATERIALS AND METHODS 
Tile fertilized eggs used in this study were purchased from Euribrid 
Belgium and I~longed to a commercial layer strain (White Hi.sex). The 
eggs were incubated ina forced-draft laboratory incubator at 37.8°Co 
30 mmHg vapour pressure, continuous lighting and were turned once 
every hour through angles of 45 ° (start of incubation = day !). Post- 
hatch chickens were kept in an aeclimat~ room with a 14L/10D photo 
period and water and feed available ad lihitum. 
The eGH used for injections was purified by affinity ehromalogra- 
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phy [20]. All injections were given intravenously and consisted of 20 
HI~ cGH/100 ~tl/animal or 100gl 0.9% saline for controls, The animals 
were killed 2 h (E 18-C3) or 1,5 h (adults) after injection, Blood samples 
were taken and the livers were immediately fi'ozen in liquid nitrogen. 
For stages E18-C3, 10 individual livers from each group were used lbr 
preparatiou ofhomogenates (1 g/4 ml buffer) as described before [19]. 
From each group. 15-30 (depending on the a£e) other livers were 
collected, yielding 10 different pools/group lbr preparation of micro- 
somal (Mx) fractions [15], For adult chickens, 10 individual livers/ 
group were used Ibr preparation of Mx fractions. 
Three different assays were used for measuring monodeiodinating 
activity: 
1. T~ to Tj conversion analyzed by radioimmunoassay of T~ after 
incubation of liver homogenates wilh T,~ [19]. The final incubation 
conditions used were 0.26 :tM T~, 2 mM DTT, 2 mM EDTA and 
- 5 mg total protein/ml (60 rain, 37°C). 
2. 5'D.I assay based on the deiodination of t"~l-labeled rT~, the pre- 
ferred substrate, by liver Mx fractions [15]. The final incubation 
conditions used were 1/.tM rT.~, S mM DTT, 2 mM EDTA and 100 
,ag Mx protein/ml (30 mln, 37°C). 
3, 5D-Ill assay based on the deiodination of ~:-~l-labeled T~,the pre- 
ferred substrate, by liver Mx fractions in the presence ofex¢¢s~ rT~ 
and 6.propyl-2-thiouracil (PTU) to block type I deiodina~¢ activity 
[15l. The final incubation conditions used were 1 nM T~ ÷ 1 ,t~M 
rTa + 1 mM PTU, 10 mM Dq-r, 2 mM EDTA and 100/.tg Mx 
protein/ml (60 min, 37°C). 
Plasma T~, Tq and GH levels were measured by radioimmanoassay 
as described before [15], while hepatic GH receptors were quantified 
following the method escribed by Vanderpooten t al. [17]. For stages 
E18-C3, the same animals were used for all measurements, while for 
the adult chickens, GH re~ptors were measured on a separate control 
group of the same stock of animals. 
3. RESULTS 
In embryonic and early posthatch chicks, cGH injec- 
tion clearly increased plasma T3 at stage El8 and CO, 
but not at stage C3, while it significantly decreased 
plasma T~ at stages CO and C3 (Table 1). Control levels 
of GH increased from stage E18-C3, while the circulat- 
ing levels 2 hours after injection were still increased at 
all stages (Table 1). The hepatic GH receptor level was 
high at stage El8, and low at stages CO and C3, and GH 
injection decreased the number of GH receptors at all 
stages (Table I). 
The control levels of hepatic 5'D-I activity showed 
only minor changes, while 5D-III activity decreased 
dramatically between stages E18-C3 (Fig. 1). The 
amount of T3 recovered in the T.~ to T~ conversion test 
was increased after GH injection at stages El 8 and C00 
but not at stage C3 (Fig. 2). GI!  induced no significant 
changes in 5'D-I activity at any stage, while it decreased 
5D-II1 activity at stages El8 and CO, but not C3 (Fig. 
1). 
In adult chickens, GH injection increased plasma T3, 
decreased plasma T,~ and hepatic 5D-111 activity and 
had no influence on hepatic 5'D-I activity (Table 1I). 
Control levels were low for 5D-III activity and were 
about one half of El 8-C3 levels for 5'D-I activity (Table 
II). The concentration of plasma GH and the specific 
hepatic GH binding were in the same range as for stage 
El8 (Table II). 
4. DISCUSSION 
The GH-induced changes in plasma T3 and '1"4 and the 
changes in the in vitro 'I"4 to T3 conversion in liver 
homogenates from stages E18-C3 confirm earlier esults 
in embryonic and posthatch chickens [3,4,18,19]. They 
all point in the direction of a stimulatory effect of GH 
on the 5'D of T4 to T~. The effect of GH treatment on 
the T.~ r.o T3 conversion by liver homogenates suggests 
that it is mediated through a change in the amount of 
enzyme responsible for the T,~ to T~ conversion, namely 
the type I enzyme. However, specific measurements of 
5"D-I activity under saturating conditions, giving relia- 
ble estimates of V,,,,, [15], clearly show that GH has no 
stimulatory effect at any stage on the amount of type I 
enzyme present in liver cells. 5D-III measurements, on
the contrary, prove that GH significantly reduces the 
amount of hepatic type III deiodinase at all stages where 
p lasma T 3 is increased (El8, CO and adults). This indi- 
cates that the increase in plasma T3 might not be due to 
an increased T~ formation, but rather to a decreased T3 
breakdown as a result of a GH-induced inactivation/ 
degradation of the type III deiodinase. This mechanism 
shows some similarities with the rapid changes in type 
II deiodinase in mammalian pituitary in response to 
hyper- or hypothyroidism [21], and is to our knowledge 
the first observation of an acute regulation of type III 
deiodinase. 
The observed ecrease in 5D-III activity is also in 
accordance with the decreased plasma rT3 levels found 
after GH injection in previous experiments [18,19], since 
Table I 
Plasma T.~, T~ and GH levels and hepatic GH receptor binding in 
embryonic and posthatcl~ chicks 2 h after inj~tion of saline(controls) 
or 20 ,uS cGH/animal. 
Controls cGH 
plasma 1~ (pmot/ml) 
EI8 0.30 + 0,05 ~ 1.87 + 0.37"'" 
CO 2.61 +_. 0.13 b 4.19 _ 0,10"" 
C3 4.13 ± 0.18 ~ 4.04 __. 0.0S 
plast~ta T4 (pmol/nll) 
E18 6.43- 1.15 ub 4.01 _ 0.64 
CO 8.13 ± 0.88 '~ 4.15 + 0.65 ..° 
C3 4.46 + 0.50 b 2.54 + 0.28'" 
plastna GH (ns,,/mf) 
El8 7.6:1:0.5 b 1116_+ 128 °'" 
CO 35.7 +_. 2.8 b 707 *_. 55'" 
C3 72.5 :t 17.3 '~ 241 -+ 14 °'' 
GH J'eceptor binding 
(% Blmg prot) 
El8 40.5 + 2.0" 6.93 __. 0.51 "*° 
C0 4.10 :I: 0.40 t' 1.89 -t- 0.40"" 
C3 4.29 --. 0.48 b 1.95 _ 0.87" 
~:alue~ represent mean + S.E.M. for 20 animals/group (6 pools/group 
for ~eeptor binding). 
"'""Means of control groups with the same letter are not significantly 
different (P<0.05, ANOVA). "P<0.05, '*P<0.01, "'P<0.001 compared 
to control group of the same age (ANOVA). 
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Fig. I. 5'D-I and 5D-III activity in hepatic microsomal fractions of 
embryotaic nd posthatch icks 2 h after injection of saline(controls) 
or 20/zg cGH/animal. Values represent mean +__ S.E.M. for 10 differ- 
ent pools/group. 
~'b~:Means of control groups with th0 same letter are not significantly 
dillereat (ANOVA, P<0.05). "'P<0.01, "'P<0.001 ¢ompar~xl to con- 
trol group of the same age (ANOVA). 
this enzyme is also responsible for at least part of the 
T4 to rT 3 conversion. The decrease in plasma T+ cannot 
be directly linked to the change in type IlI deiodinase 
level. It could however be due to a negative feedback on 
thyroidal T4 release caused by the increased plasma Ta 
Table 1I 
Plasma Ta, 1"4 and GH and hepatic 5'D.I activity, 5D-Ill activity and 
GH receptor binding in adult chickens 1,5 h after injection of sa- 
line(controls) or20/,tg eGH/animal 
Controls cGI-I 
plasma T3 (pmol/ml) 1.28 ± 0.08 1.75 _+ 0.22" 
plasma T+ (pmol/ml) 4.38:1:0.46 3.04 _+ 0.51" 
5'D-I activity 81.7 +- 6.2 84.8 _+ 8.7 
(pmol rT~ deiodinated 
/min/mg prot) 
5D-Ill activity 1.16 :I: 0.13 0,72 :I: 0,08' 
(fmol T~ deiodinatcd 
/min/m 8 prot) 
plasma GH (ng/ml) 14.8 +_ 2.6 20.4 ± 2.8 
GH receptor binding 32.6 :t: 2.3 
(% Blmg prot) 
Values represent mean +_ S.E.M. for 10 animals/group (6 ools/group 
for receptor binding). "P<0.05 compared tocontrol group (ANOVA). 
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Fig, 2. T4 to T~ conversion i  liver homogenates of embryonic and 
posthatch icks 2 h after injection of saline(controls) r 201tg ¢GH/ 
animal. Values represent mean *_. S.E.M. for 10 individual livers/ 
group. 
",b,'Means ofcontrol groups with the same letter are not significantly 
different (ANOVA, P<0.05). 'P<0.05, "'P<0.001 compared tocon- 
trol group of the same age (ANOVA) 
levels. Another possibility is that GH can stimulate cel- 
lular uptake of T~ in the chicken as has been shown in 
the rat [22], resulting in decreased plasma levels. The 
above results also clearly indicate that the I"4 to T~ 
conversion test used before, cannot be regarded as a 
reliable estimate tbr pure 5'D activity. The amount of 
T.a accumulating in incubations of'l"4 with chicken liver 
homogenates is not only dependent on the rate ofT+ 5'D 
to T3 by the type I deiodinase but also on the activity 
of the type III enzyme which catalyzes the 5D ofT+ to 
rT 3 and of T3 to T2. 
As was already seen in previous tudies, the stimula- 
tory effect ofa GH injection on plasma T~ is not present 
in normally fed C3 chicks, but is found again in adult 
chickens [4,18,19]. This corresponds with the observa- 
tion that, although epatic ontrol levels of 5D,III ac- 
tivity are low in both groups, GH decreases 5D-III 
activity in adult but not in 3-day-old chickens. An ex- 
planation for this difference might be found in the num- 
ber of receptor sites available for GH binding. C3 is the 
only stage in the above experiments where the liver 
shows both low 5D.III levels and a low amount of GH 
receptors. Those two factors taken together might result 
in the inability of the injected GH to increase plasma T.~ 
at that stage, even though its effect on plasma T+ has not 
yet completely disappeared. 
It can be concluded that the stimulator), effect of GH 
on plasma T~ in the chicken is not mediated through an 
increase in the amount of hepatic type I deiodinase, but 
through an acute decrease in hepatic type I11 deiodi- 
nase, resulting in a decreased egradation of T~. The 
combined effect of decreased hepatic G H receptor avail- 
ability and decreased hepatic type 111 enzyme content, 
might explain the absence of T~ stimulation in 3 days 
okl chicks. 
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